SHI Dongfang,FU Changjin,CHENG Xi,ZHU Jianghua,WEN Jie,GU Jie
申请号：
SI201630859
公开号：
SI3348557T1
申请日:
2016.09.08
申请国别(地区):
SI
年份:
2020
代理人:
摘要：
Provided are a compound as represented in formula (I), a pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and uses thereof. The compound as represented in formula (I) and the pharmaceutically acceptable salts thereof are used in the preparation of medicines for the treatment or prevention of hyperuricemia or gout by means of uric acid excretion.
